These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 994669)

  • 1. [Surgical treatment of malignant melanoma (author's transl)].
    Encke A; Best A
    Langenbecks Arch Chir; 1976 Nov; 342():527-32. PubMed ID: 994669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regional lymph node dissection in malignant melanomas of the skin. Indications and results (author's transl)].
    Lacour J; Petit JY; Sancho H; Pacheco LA; Prade M
    Chirurgie; 1978 Nov; 104(10):955-9. PubMed ID: 747947
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant melanoma: microstages and individualized therapy.
    Tonak J; Hermanek P; Groitl H
    Aust N Z J Surg; 1978 Jun; 48(3):282-6. PubMed ID: 281219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Surgical treatment of malignant melanoma of the skin with special reference to the vertical tumor diameter].
    Waclawiczek HW; Umlauft M; Weitgasser R
    Chirurg; 1984 Aug; 55(8):508-11. PubMed ID: 6488996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of malignant melanoma (clinical stages I and II) (author's transl)].
    Tonak J; Hermanek P; Hornstein OP; Weidner F
    Dtsch Med Wochenschr; 1976 Mar; 101(12):435-50. PubMed ID: 943283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The wide and deep excision of primary malignant melanoma: a dogma on the decline.
    Piérard-Franchimont C; Piérard GE
    Acta Clin Belg; 1998 Apr; 53(2):98-9. PubMed ID: 9639947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
    Tas F; Erturk K
    Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiation therapy of malignant melanoma (author's transl)].
    Scherer E; Makoski HB
    Langenbecks Arch Chir; 1976 Nov; 342():545-8. PubMed ID: 825693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is prophylactic popliteal node dissection necessary in malignant melanoma of the foot?
    Abu-Eshy S
    East Afr Med J; 1995 May; 72(5):338. PubMed ID: 7555894
    [No Abstract]   [Full Text] [Related]  

  • 10. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review and current perspectives of cutaneous malignant melanoma.
    Evans RA
    J Am Coll Surg; 1994 Dec; 179(6):764-7. PubMed ID: 7952494
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Richards PC; Maddox WA
    Cancer; 1979 Mar; 43(3):883-8. PubMed ID: 427730
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of malignant melanoma: wide excision alone vs lymphadenectomy.
    Conrad FG
    Arch Surg; 1972 Apr; 104(4):587-93. PubMed ID: 5013800
    [No Abstract]   [Full Text] [Related]  

  • 14. Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients.
    Milton GW; Shaw HM; McCarthy WH; Pearson L; Balch CM; Soong SJ
    Br J Surg; 1982 Feb; 69(2):108-11. PubMed ID: 7059764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Principles of the surgical treatment of malignoma of the facial area (author's transl)].
    Haas E
    Laryngol Rhinol Otol (Stuttg); 1980 Oct; 59(10):603-10. PubMed ID: 7453416
    [No Abstract]   [Full Text] [Related]  

  • 16. Melanoma today does not require radical surgery.
    Lang NP; Stair JM; Degges RD; Thompson C; Garner H; Baker GF; Westbrook KC
    Am J Surg; 1984 Dec; 148(6):723-6. PubMed ID: 6507743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis of malignant melanoma following dissection regional lymph node metastases].
    Sprakel B; Stenschke F; Unnewehr M; Ladas A; Senninger N
    Chirurg; 2003 Jan; 74(1):55-60. PubMed ID: 12552406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma.
    Reintgen DS; Cox EB; McCarty KS; Vollmer RT; Seigler HF
    Ann Surg; 1983 Sep; 198(3):379-85. PubMed ID: 6615058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous malignant melanomas. Reflections based upon 26 cases seen in the Cocody teaching Hospital, Abidjan (author's transl)].
    Allangba K; Djibo W; Lambin Y; Kouassi JC
    Chirurgie; 1979; 105(9):808-11. PubMed ID: 231504
    [No Abstract]   [Full Text] [Related]  

  • 20. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
    Kapelanski DP; Block GE; Kaufman M
    Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.